Author:
Miao Yi,Cai Baobao,Lu Zipeng
Reference78 articles.
1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022
2. Cancer incidence and mortality in China, 2016;Zheng;J Natl Cancer Center,2022
3. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial;Neoptolemos;Lancet.,2017
4. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer;Conroy;N Engl J Med,2018
5. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pankreaskarzinom;Allgemein- und Viszeralchirurgie up2date;2024-08